DOVATO is a prescription medication used in the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kilograms. It is a combination antiretroviral medication that contains two active ingredients: dolutegravir, an integrase strand transfer inhibitor (INSTI), and lamivudine, a nucleoside reverse transcriptase inhibitor (NRTI). This combination works by interfering with the virus's ability to replicate and spread, helping to reduce the amount of HIV in the body. DOVATO is taken as a single tablet once daily and is used as part of antiretroviral therapy (ART) for individuals with HIV-1. It is notable for its use in certain patients as a complete regimen for the treatment of HIV-1 infection without the need for other HIV-1 medications. As with any medication, it is important to use DOVATO under the guidance of a healthcare provider, and it is not a cure for HIV or AIDS.
When using DOVATO, a combination medication used in the treatment of HIV, it's crucial to adhere strictly to your doctor's instructions and thoroughly read the label that comes with the medicine. DOVATO can cause side effects that may impair your ability to drive or operate machinery safely. Common side effects include headache, diarrhea, nausea, and fatigue. Although rare, more serious side effects such as liver problems, allergic reactions, or a worsening of a previously existing hepatitis B infection can occur. It's of utmost importance to inform your doctor about all other medications you are taking, as DOVATO can interact with other drugs, potentially leading to adverse effects. Always consult your healthcare provider if you experience any unusual symptoms or if you have concerns about the medication's effects on your daily activities.